ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.775,80
0,17%
S&P 500
5.428,53
-0,10%
US Dollar vs BRL
5,3776
0,27%
Bitcoin
65.366,17
-2,08%
Brent Oil
82,39
0,51%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Synlogic Com USD0.001 (MIRN)

  7. Synlogic Com USD0.001 (MIRN) Notícias

MIRN

MIRNA THERAPEUTICS, INC. (MIRN)

Synlogic Com USD0.001
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MIRN
DataHoraFonteTítuloCódigoCompanhia
26/09/201717:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MIRNSynlogic Com USD0.001
19/09/201713:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201715:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201715:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MIRNSynlogic Com USD0.001
06/09/201707:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201717:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201717:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIRNSynlogic Com USD0.001
28/08/201717:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MIRNSynlogic Com USD0.001
25/08/201709:15Business WireMirna Therapeutics Announces Results of Annual Meeting of StockholdersNASDAQ:MIRNSynlogic Com USD0.001
04/08/201707:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MIRNSynlogic Com USD0.001
14/07/201707:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MIRNSynlogic Com USD0.001
13/07/201717:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MIRNSynlogic Com USD0.001
11/07/201709:14Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MIRNSynlogic Com USD0.001
21/06/201718:13Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MIRNSynlogic Com USD0.001
09/06/201717:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MIRNSynlogic Com USD0.001
16/05/201707:30Business WireSynlogic and Mirna Therapeutics Agree to MergerNASDAQ:MIRNSynlogic Com USD0.001
09/05/201718:30Business WireMirna Therapeutics Reports First Quarter 2017 Financial ResultsNASDAQ:MIRNSynlogic Com USD0.001
15/03/201707:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MIRNSynlogic Com USD0.001
14/03/201719:11Business WireMirna Therapeutics Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016NASDAQ:MIRNSynlogic Com USD0.001
14/02/201714:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MIRNSynlogic Com USD0.001
10/11/201619:59Business WireMirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
20/09/201617:05Business WireMirna Therapeutics Halts Phase 1 Clinical Study of MRX34NASDAQ:MIRNSynlogic Com USD0.001
31/08/201608:00Business WireMirna Therapeutics to Participate in Two Healthcare Investor Conferences in SeptemberNASDAQ:MIRNSynlogic Com USD0.001
15/08/201608:00Business WireMirna Therapeutics Reports Second Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
05/07/201608:00Business WireMirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare ConferenceNASDAQ:MIRNSynlogic Com USD0.001
30/06/201608:00Business WireMirna Therapeutics Appoints Perry Nisen, M.D., Ph.D., to Its Board of DirectorsNASDAQ:MIRNSynlogic Com USD0.001
06/06/201613:00Business WireMirna Therapeutics Announces Clinical Data on its Lead microRNA Therapeutic Presented at ASCONASDAQ:MIRNSynlogic Com USD0.001
12/05/201617:05Business WireMirna Therapeutics Reports First Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
27/04/201617:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MIRNSynlogic Com USD0.001
27/04/201617:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MIRNSynlogic Com USD0.001
 Apresentando as notícias mais relevantes sobre:NASDAQ:MIRN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
AMAR3
LOJAS MARISA ON
BOV
OIBR3
OI ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AMER3
Americanas ON
BOV
TECN3
TECHNOS ON
BOV
DASA3
DASA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
IRBR3
IRB BRASIL ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
RCSL4
RECRUSUL PN
BOV
POMO4
MARCOPOLO PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados